These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 22913627)

  • 1. Aβ oligomer toxicity inhibitor protects memory in models of synaptic toxicity.
    Scopes DI; O'Hare E; Jeggo R; Whyment AD; Spanswick D; Kim EM; Gannon J; Amijee H; Treherne JM
    Br J Pharmacol; 2012 Sep; 167(2):383-92. PubMed ID: 22913627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MRZ-99030 - A novel modulator of Aβ aggregation: II - Reversal of Aβ oligomer-induced deficits in long-term potentiation (LTP) and cognitive performance in rats and mice.
    Rammes G; Gravius A; Ruitenberg M; Wegener N; Chambon C; Sroka-Saidi K; Jeggo R; Staniaszek L; Spanswick D; O'Hare E; Palmer P; Kim EM; Bywalez W; Egger V; Parsons CG
    Neuropharmacology; 2015 May; 92():170-82. PubMed ID: 25637092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RS-0406 arrests amyloid-beta oligomer-induced behavioural deterioration in vivo.
    O'Hare E; Scopes DI; Treherne JM; Norwood K; Spanswick D; Kim EM
    Behav Brain Res; 2010 Jun; 210(1):32-7. PubMed ID: 20138088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel 5-aryloxypyrimidine SEN1576 as a candidate for the treatment of Alzheimer's disease.
    O'Hare E; Scopes DI; Kim EM; Palmer P; Spanswick D; McMahon B; Amijee H; Nerou E; Treherne JM; Jeggo R
    Int J Neuropsychopharmacol; 2014 Jan; 17(1):117-26. PubMed ID: 24103729
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers I: Abeta 42 oligomer binding to specific neuronal receptors is displaced by drug candidates that improve cognitive deficits.
    Izzo NJ; Staniszewski A; To L; Fa M; Teich AF; Saeed F; Wostein H; Walko T; Vaswani A; Wardius M; Syed Z; Ravenscroft J; Mozzoni K; Silky C; Rehak C; Yurko R; Finn P; Look G; Rishton G; Safferstein H; Miller M; Johanson C; Stopa E; Windisch M; Hutter-Paier B; Shamloo M; Arancio O; LeVine H; Catalano SM
    PLoS One; 2014; 9(11):e111898. PubMed ID: 25390368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bis(propyl)-cognitin Prevents β-amyloid-induced Memory Deficits as Well as Synaptic Formation and Plasticity Impairments via the Activation of PI3-K Pathway.
    Jiang L; Huang M; Xu S; Wang Y; An P; Feng C; Chen X; Wei X; Han Y; Wang Q
    Mol Neurobiol; 2016 Aug; 53(6):3832-3841. PubMed ID: 26160762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection against β-amyloid-induced synaptic and memory impairments via altering β-amyloid assembly by bis(heptyl)-cognitin.
    Chang L; Cui W; Yang Y; Xu S; Zhou W; Fu H; Hu S; Mak S; Hu J; Wang Q; Ma VP; Choi TC; Ma ED; Tao L; Pang Y; Rowan MJ; Anwyl R; Han Y; Wang Q
    Sci Rep; 2015 Jul; 5():10256. PubMed ID: 26194093
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapeutic significance of NR2B-containing NMDA receptors and mGluR5 metabotropic glutamate receptors in mediating the synaptotoxic effects of β-amyloid oligomers on long-term potentiation (LTP) in murine hippocampal slices.
    Rammes G; Hasenjäger A; Sroka-Saidi K; Deussing JM; Parsons CG
    Neuropharmacology; 2011 May; 60(6):982-90. PubMed ID: 21310164
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's therapeutics targeting amyloid beta 1-42 oligomers II: Sigma-2/PGRMC1 receptors mediate Abeta 42 oligomer binding and synaptotoxicity.
    Izzo NJ; Xu J; Zeng C; Kirk MJ; Mozzoni K; Silky C; Rehak C; Yurko R; Look G; Rishton G; Safferstein H; Cruchaga C; Goate A; Cahill MA; Arancio O; Mach RH; Craven R; Head E; LeVine H; Spires-Jones TL; Catalano SM
    PLoS One; 2014; 9(11):e111899. PubMed ID: 25390692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo.
    Yang F; Lim GP; Begum AN; Ubeda OJ; Simmons MR; Ambegaokar SS; Chen PP; Kayed R; Glabe CG; Frautschy SA; Cole GM
    J Biol Chem; 2005 Feb; 280(7):5892-901. PubMed ID: 15590663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orally bioavailable small molecule drug protects memory in Alzheimer's disease models.
    O'Hare E; Scopes DI; Kim EM; Palmer P; Jones M; Whyment AD; Spanswick D; Amijee H; Nerou E; McMahon B; Treherne JM; Jeggo R
    Neurobiol Aging; 2013 Apr; 34(4):1116-25. PubMed ID: 23164690
    [TBL] [Abstract][Full Text] [Related]  

  • 12. WASP-1, a canonical Wnt signaling potentiator, rescues hippocampal synaptic impairments induced by Aβ oligomers.
    Vargas JY; Ahumada J; Arrázola MS; Fuenzalida M; Inestrosa NC
    Exp Neurol; 2015 Feb; 264():14-25. PubMed ID: 25450465
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crocin improved amyloid beta induced long-term potentiation and memory deficits in the hippocampal CA1 neurons in freely moving rats.
    Hadipour M; Kaka G; Bahrami F; Meftahi GH; Pirzad Jahromi G; Mohammadi A; Sahraei H
    Synapse; 2018 May; 72(5):e22026. PubMed ID: 29357117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The flavonoid baicalein rescues synaptic plasticity and memory deficits in a mouse model of Alzheimer's disease.
    Gu XH; Xu LJ; Liu ZQ; Wei B; Yang YJ; Xu GG; Yin XP; Wang W
    Behav Brain Res; 2016 Sep; 311():309-321. PubMed ID: 27233830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glycyrrhiza and Uncaria Hook contribute to protective effect of traditional Japanese medicine yokukansan against amyloid β oligomer-induced neuronal death.
    Kanno H; Kawakami Z; Iizuka S; Tabuchi M; Mizoguchi K; Ikarashi Y; Kase Y
    J Ethnopharmacol; 2013 Aug; 149(1):360-70. PubMed ID: 23838475
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Certain inhibitors of synthetic amyloid beta-peptide (Abeta) fibrillogenesis block oligomerization of natural Abeta and thereby rescue long-term potentiation.
    Walsh DM; Townsend M; Podlisny MB; Shankar GM; Fadeeva JV; El Agnaf O; Hartley DM; Selkoe DJ
    J Neurosci; 2005 Mar; 25(10):2455-62. PubMed ID: 15758153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective effects of EphB2 on Aβ1-42 oligomer-induced neurotoxicity and synaptic NMDA receptor signaling in hippocampal neurons.
    Geng D; Kang L; Su Y; Jia J; Ma J; Li S; Du J; Cui H
    Neurochem Int; 2013 Oct; 63(4):283-90. PubMed ID: 23831214
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Alzheimer's disease like pathology induced six weeks after aggregated amyloid-beta injection in rats: increased oxidative stress and impaired long-term memory with anxiety-like behavior.
    Sharma S; Verma S; Kapoor M; Saini A; Nehru B
    Neurol Res; 2016 Sep; 38(9):838-50. PubMed ID: 27431920
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Nicotinamide mononucleotide protects against β-amyloid oligomer-induced cognitive impairment and neuronal death.
    Wang X; Hu X; Yang Y; Takata T; Sakurai T
    Brain Res; 2016 Jul; 1643():1-9. PubMed ID: 27130898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures.
    Bate C; Williams A
    Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.